Structure of the HIV-1 frameshift site RNA bound to a small molecule inhibitor of viral replication

ACS Chemical Biology

Volumn 6, Issue 8, 2011, Pages 857-864

  Marcheschi, Ryan J ^a   Tonelli, Marco ^a   Kumar, Arvind ^b   Butcher, Samuel E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATE; RNA;

ARTICLE; BASE PAIRING; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS REPLICATION;

ANTI-HIV AGENTS; BINDING SITES; FRAMESHIFTING, RIBOSOMAL; HIV INFECTIONS; HIV-1; HUMANS; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; NUCLEIC ACID CONFORMATION; RNA STABILITY; RNA, VIRAL; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80051955672     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb200082d     Document Type: Article

References (73)

1. Ward, D. E. (1998) The AmFAR AIDS Handbook: The Complete Guide to Understanding HIV and AIDS, W. W. Norton & Co., New York, NY.
2. UNAIDS (2008) 2008 Report on the Global AIDS Epidemic, UNAIDS, Geneva, Switzerland.
3. Lefebvre, E. and Schiffer, C. A. (2008) Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir AIDS Rev. 10, 131-142
4. Schiller, D. S. and Youssef-Bessler, M. (2009) Etravirine: A second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIV Clin. Ther. 31, 692-704
5. Condra, J. H., Miller, M. D., Hazuda, D. J., and Emini, E. A. (2002) Potential new therapies for the treatment of HIV-1 infection Annu. Rev. Med. 53, 541-555 (Pubitemid 34177895)
6. Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., and Miller, M. D. (2000) Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells Science 287, 646-650 (Pubitemid 30070911)
7. Moore, R. D. and Chaisson, R. E. (1999) Natural history of HIV infection in the era of combination antiretroviral therapy Aids 13, 1933-1942 (Pubitemid 29509554)
8. Palmer, S., Maldarelli, F., Wiegand, A., Bernstein, B., Hanna, G. J., Brun, S. C., Kempf, D. J., Mellors, J. W., Coffin, J. M., and King, M. S. (2008) Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy Proc. Natl. Acad. Sci. U.S.A. 105, 3879-3884 (Pubitemid 351723493)
9. Maldarelli, F., Palmer, S., King, M. S., Wiegand, A., Polis, M. A., Mican, J., Kovacs, J. A., Davey, R. T., Rock-Kress, D., Dewar, R., Liu, S., Metcalf, J. A., Rehm, C., Brun, S. C., Hanna, G. J., Kempf, D. J., Coffin, J. M., and Mellors, J. W. (2007) ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia PLoS Pathog. 3, e46
10. Bartlett, J. A., DeMasi, R., Quinn, J., Moxham, C., and Rousseau, F. (2001) Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults AIDS 15, 1369-1377 (Pubitemid 32663904)
11. Gonsalez, C. R., Alcalde, R., Nishiya, A., Barreto, C. C., Silva, F. E., de Almeida, A., Mendonca, M., Ferreira, F., Fernandes, S. S., Casseb, J., and Duarte, A. J. (2007) Drug resistance among chronic HIV-1-infected patients naive for use of anti-retroviral therapy in Sao Paulo city Virus Res. 129, 87-90 (Pubitemid 47595356)
12. Condra, J. H., Schleif, W. A., Blahy, O. M., Gabryelski, L. J., Graham, D. J., Quintero, J. C., Rhodes, A., Robbins, H. L., Roth, E., and Shivaprakash, M. 1995, In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors Nature 374, 569-571
13. Palma, A. C., Araujo, F., Duque, V., Borges, F., Paixao, M. T., and Camacho, R. (2007) Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal Infect. Genet. Evol. 7, 391-398 (Pubitemid 46667770)
14. Booth, C. L., Garcia-Diaz, A. M., Youle, M. S., Johnson, M. A., Phillips, A., and Geretti, A. M. (2007) Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection J. Antimicrob. Chemother. 59, 517-524 (Pubitemid 47073459)
15. Clavel, F. and Hance, A. J. (2004) HIV drug resistance N. Engl. J. Med. 350, 1023-1035 (Pubitemid 38269279)
16. Dinman, J. D., Ruiz-Echevarria, M. J., and Peltz, S. W. (1998) Translating old drugs into new treatments: ribosomal frameshifting as a target for antiviral agents Trends Biotechnol. 16, 190-196 (Pubitemid 128712952)
17. Hung, M., Patel, P., Davis, S., and Green, S. R. (1998) Importance of ribosomal frameshifting for human immunodeficiency virus type 1 particle assembly and replication J. Virol. 72, 4819-4824 (Pubitemid 28215658)
18. McNaughton, B. R., Gareiss, P. C., and Miller, B. L. (2007) Identification of a selective small-molecule ligand for HIV-1 frameshift-inducing stem-loop RNA from an 11,325 member resin bound dynamic combinatorial library J. Am. Chem. Soc. 129, 11306-11307 (Pubitemid 47555529)
19. Staple, D. W., Venditti, V., Niccolai, N., Elson-Schwab, L., Tor, Y., and Butcher, S. E. (2008) Guanidinoneomycin B recognition of an HIV-1 RNA helix ChemBioChem 9, 93-102
20. Horiya, S., Koh, C. S., Matsufuji, S., and Harada, K. (2008) Analysis of the interaction between selected RNA-binding peptides and a target RNA containing a bulge and a GNRA-type tetraloop Nucleic Acids Symp. Ser. 209-210
21. Dulude, D., Theberge-Julien, G., Brakier-Gingras, L., and Heveker, N. (2008) Selection of peptides interfering with a ribosomal frameshift in the human immunodeficiency virus type 1 RNA 14, 981-991 (Pubitemid 351574919)
22. Jacks, T., Power, M. D., Masiarz, F. R., Luciw, P. A., Barr, P. J., and Varmus, H. E. (1988) Characterization of ribosomal frameshifting in HIV-1 gag-pol expression Nature 331, 280-283 (Pubitemid 18040598)
23. Brierley, I. and Pennell, S. (2001) Structure and function of the stimulatory RNAs involved in programmed eukaryotic-1 ribosomal frameshifting Cold Spring Harbor Symp. Quant. Biol. 66, 233-248 (Pubitemid 36097930)
24. Telenti, A., Martinez, R., Munoz, M., Bleiber, G., Greub, G., Sanglard, D., and Peters, S. (2002) Analysis of natural variants of the human immunodeficiency virus type 1 gag-pol frameshift stem-loop structure J. Virol. 76, 7868-7873 (Pubitemid 34761010)
25. Bidou, L., Stahl, G., Grima, B., Liu, H., Cassan, M., and Rousset, J. P. (1997) In vivo HIV-1 frameshifting efficiency is directly related to the stability of the stem-loop stimulatory signal RNA 3, 1153-1158 (Pubitemid 27424282)
26. Parkin, N. T., Chamorro, M., and Varmus, H. E. (1992) Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on downstream mRNA secondary structure: demonstration by expression in vivo J. Virol. 66, 5147-5151
27. Park, J. and Morrow, C. D. (1991) Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production J. Virol. 65, 5111-5117
28. Kim, Y. G., Maas, S., and Rich, A. (2001) Comparative mutational analysis of cis-acting RNA signals for translational frameshifting in HIV-1 and HTLV-2 Nucleic Acids Res. 29, 1125-1131 (Pubitemid 32186198)
29. Leger, M., Sidani, S., and Brakier-Gingras, L. (2004) A reassessment of the response of the bacterial ribosome to the frameshift stimulatory signal of the human immunodeficiency virus type 1 RNA 10, 1225-1235 (Pubitemid 38989008)
30. Dulude, D., Baril, M., and Brakier-Gingras, L. (2002) Characterization of the frameshift stimulatory signal controlling a programmed -1 ribosomal frameshift in the human immunodeficiency virus type 1 Nucleic Acids Res. 30, 5094-5102 (Pubitemid 36033026)
31. Dulude, D., Berchiche, Y. A., Gendron, K., Brakier-Gingras, L., and Heveker, N. (2006) Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1 Virology 345, 127-136 (Pubitemid 43107578)
32. Shehu-Xhilaga, M., Crowe, S. M., and Mak, J. (2001) Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity J. Virol. 75, 1834-1841 (Pubitemid 32110173)
33. Marcheschi, R. J., Mouzakis, K. D., and Butcher, S. E. (2009) Selection and characterization of small molecules that bind the HIV-1 frameshift site RNA ACS Chem. Biol. 4, 844-854
34. Staple, D. W. and Butcher, S. E. (2003) Solution structure of the HIV-1 frameshift inducing stem-loop RNA Nucleic Acids Res. 31, 4326-4331 (Pubitemid 37441793)
35. Staple, D. W. (2006) Structural and Thermodynamic Investigation of the HIV-1 Frameshift Inducing RNA, Ph.D. thesis, University of Wisconsin-Madison.
36. Staple, D. W. and Butcher, S. E. (2005) Solution structure and thermodynamic investigation of the HIV-1 frameshift inducing element J. Mol. Biol. 349, 1011-1023 (Pubitemid 40779622)
37. Dalvit, C., Pevarello, P., Tato, M., Veronesi, M., Vulpetti, A., and Sundstrom, M. (2000) Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water J. Biomol. NMR 18, 65-68
38. Dalvit, C., Fogliatto, G., Stewart, A., Veronesi, M., and Stockman, B. (2001) WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability J. Biomol. NMR 21, 349-359 (Pubitemid 34071389)
39. Johnson, E. C., Feher, V. A., Peng, J. W., Moore, J. M., and Williamson, J. R. (2003) Application of NMR SHAPES screening to an RNA target J. Am. Chem. Soc. 125, 15724-15725 (Pubitemid 37553672)
40. Bindslev, N. (2008) Drug-Acceptor Interactions: Modeling Theoretical Tools to Test and Evaluate Experimental Equilibrium Effects, Co-Action Publishing, Sweden.
41. Dominguez, C., Boelens, R., and Bonvin, A. M. (2003) HADDOCK: a protein-protein docking approach based on biochemical or biophysical information J. Am. Chem. Soc. 125, 1731-1737 (Pubitemid 36232568)
42. de Vries, S. J., van Dijk, A. D., Krzeminski, M., van Dijk, M., Thureau, A., Hsu, V., Wassenaar, T., and Bonvin, A. M. (2007) HADDOCK versus HADDOCK: new features and performance of HADDOCK2.0 on the CAPRI targets Proteins 69, 726-733 (Pubitemid 350210131)
43. van Dijk, A. D. and Bonvin, A. M. (2006) Solvated docking: introducing water into the modelling of biomolecular complexes Bioinformatics 22, 2340-2347 (Pubitemid 44566962)
44. Case, D. A., Cheatham, T. E., 3rd, Darden, T., Gohlke, H., Luo, R., Merz, K. M., Jr., Onufriev, A., Simmerling, C., Wang, B., and Woods, R. J. (2005) The Amber biomolecular simulation programs J. Comput. Chem. 26, 1668-1688 (Pubitemid 43076180)
45. Xu, D., Landon, T., Greenbaum, N. L., and Fenley, M. O. (2007) The electrostatic characteristics of G.U wobble base pairs Nucleic Acids Res. 35, 3836-3847 (Pubitemid 47244675)
46. Munde, M., Kumar, A., Nhili, R., Depauw, S., David-Cordonnier, M. H., Ismail, M. A., Stephens, C. E., Farahat, A. A., Batista-Parra, A., Boykin, D. W., and Wilson, W. D. (2010) DNA minor groove induced dimerization of heterocyclic cations: compound structure, binding affinity, and specificity for a TTAA site J. Mol. Biol. 402, 847-864
47. Paine, M. F., Wang, M. Z., Generaux, C. N., Boykin, D. W., Wilson, W. D., De Koning, H. P., Olson, C. A., Pohlig, G., Burri, C., Brun, R., Murilla, G. A., Thuita, J. K., Barrett, M. P., and Tidwell, R. R. (2010) Diamidines for human African trypanosomiasis Curr. Opin. Invest. Drugs 11, 876-883
48. Wang, M. Z., Zhu, X. H., Srivastava, A., Liu, Q., Sweat, J. M., Pandharkar, T., Stephens, C. E., Riccio, E., Parman, T., Munde, M., Mandal, S., Madhubala, R., Tidwell, R. R., Wilson, W. D., Boykin, D. W., Hall, J. E., Kyle, D. E., and Werbovetz, K. A. (2010) Novel arylimidamides for treatment of visceral Leishmaniasis Antimicrob. Agents Chemother. 54, 2507-2516
49. Parsons, J., Castaldi, M. P., Dutta, S., Dibrov, S. M., Wyles, D. L., and Hermann, T. (2009) Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA Nat. Chem. Biol. 5, 823-825
50. Pedersen, J. S., Bejerano, G., Siepel, A., Rosenbloom, K., Lindblad-Toh, K., Lander, E. S., Kent, J., Miller, W., and Haussler, D. (2006) Identification and classification of conserved RNA secondary structures in the human genome PLoS Comput. Biol. 2, e33
51. Hajduk, P. J. and Greer, J. (2007) A decade of fragment-based drug design: strategic advances and lessons learned Nat. Rev. Drug Discovery 6, 211-219 (Pubitemid 46344625)
52. Bodoor, K., Boyapati, V., Gopu, V., Boisdore, M., Allam, K., Miller, J., Treleaven, W. D., Weldeghiorghis, T., and Aboul-ela, F. (2009) Design and implementation of an ribonucleic acid (RNA) directed fragment library J. Med. Chem. 52, 3753-3761
53. Marcheschi, R. J., Staple, D. W., and Butcher, S. E. (2007) Programmed ribosomal frameshifting in SIV is induced by a highly structured RNA stem-loop J. Mol. Biol. 373, 652-663 (Pubitemid 47488399)
54. John, D. M. and Weeks, K. M. (2000) van't Hoff enthalpies without baselines Protein Sci. 9, 1416-1419 (Pubitemid 30602299)
55. Piotto, M., Saudek, V., and Sklenar, V. (1992) Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions J. Biomol. NMR 2, 661-665
56. Zweckstetter, M. and Bax, A. (2000) Prediction of sterically induced alignment in a dilute liquid crystalline phase: aid to protein structure determination by NMR J. Am. Chem. Soc. 122, 3791-3792 (Pubitemid 30233459)
57. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes J. Biomol. NMR 6, 277-293
58. Arnott, S., Hukins, D. W., Dover, S. D., Fuller, W., and Hodgson, A. R. (1973) Structures of synthetic polynucleotides in the A-RNA and A′-RNA conformations: x-ray diffraction analyses of the molecular conformations of polyadenylic acid-polyuridylic acid and polyinosinic acid-polycytidylic acid J. Mol. Biol. 81, 107-122
59. Chandrasekaran, R. and Arnott, S. (1989) In Landolt-Bornstein, New Series, Group VII (Saenger, W., Ed.), pp 31-170, Springer, Berlin, Germany.
60. Saenger, W. (1984) Principles of Nucleic Acids, Springer-Verlag, New York.
61. Davis, J. H., Tonelli, M., Scott, L. G., Jaeger, L., Williamson, J. R., and Butcher, S. E. (2005) RNA helical packing in solution: NMR structure of a 30 kDa GAAA tetraloop-receptor complex J. Mol. Biol. 351, 371-382 (Pubitemid 41007755)
62. Kleywegt, G. J. (1995) Dictionaries for Heteros CCP4/ESF-EACBM Newsletter on Protein Crystallography 31, 45-50
63. Kleywegt, G. J. (1996) Making the most of your search model CCP4/ESF-EACBM Newsletter on Protein Crystallography 32, 32-36
64. Kleywegt, G. J., Zou, J. Y., Kjeldgaard, M., and Jones, T. A. (2001) Around O, in International Tables for Crystallography, Vol. F. Crystallography of Biological Macromolecules (Rossmann, M. G. and Arnold, E., Ed.), pp 353-356, 366-367, Kluwer Academic Publishers, Dordrecht, The Netherlands.
65. Kleywegt, G. J. (2007) Crystallographic refinement of ligand complexes Acta Crystallogr. D Biol Crystallogr 63, 94-100 (Pubitemid 46141484)
66. Kleywegt, G. J., Henrick, K., Dodson, E. J., and van Aalten, D. M. (2003) Pound-wise but penny-foolish: How well do micromolecules fare in macromolecular refinement? Structure 11, 1051-1059 (Pubitemid 37103067)
67. Kleywegt, G. J. and Jones, T. A. (1997) Model building and refinement practice Methods Enzymol. 277, 208-230 (Pubitemid 27390923)
68. Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., and Mackerell, A. D., Jr. (2010) CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields J. Comput. Chem. 31, 671-690
69. Tsui, V. and Case, D. A. (2000) Theory and applications of the generalized Born solvation model in macromolecular simulations Biopolymers 56, 275-291 (Pubitemid 34105875)
70. Cornell, W. D., Cieplak, P., Bayly, C. I., Gould, I. R., Merz, K. M., Ferguson, D. M., Spellmeyer, D. C., Fox, T., Caldwell, J. W., and Kollman, P. A. (1995) A second generation force field for the simulation of proteins, nucleic acids, and organic molecules J. Am. Chem. Soc. 117, 5179-5197
71. Junmei, W., Romain, M. W., James, W. C., Peter, A. K., and David, A. C. (2004) Development and testing of a general amber force field J. Comput. Chem. 25, 1157-1174
72. Venditti, V., Clos, Ii, L., Niccolai, N., and Butcher, S. E. (2009) Minimum-energy path for a U6 RNA conformational change involving protonation, base-pair rearrangement and base flipping J. Mol. Biol. 391, 894-905
73. Koradi, R., Billeter, M., and Wuthrich, K. (1996) MOLMOL: a program for display and analysis of macromolecular structures J. Mol. Graph. 14, 51-55 (Pubitemid 26152976)